Aviva
RXO icon

Aviva’s RXO RXO Stock Holding History

Aviva’s Portfolio RXO Stock Details RXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,478
Closed -$232K – 1031
2022
Q4 		$232K Buy
+13,478
New +$239K ﹤0.01% 983

Other funds holding RXO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Aviva's RXO Position: Q1 2023 in Review

Aviva sold out of RXO (RXO) in Q1 2023, closing a stake of 13,478 shares — an estimated $232K sold.

Aviva first reported a position in RXO in Q4 2022 and held it in 1 quarter. The position peaked at $232K in Q4 2022. 281 funds tracked by Wall St. Rank hold RXO as of Q1 2023.

  • Aviva reported no remaining RXO position as of Q1 2023 after selling out during the quarter.
  • Aviva sold 13,478 RXO shares in Q1 2023, an estimated $232K.
  • Aviva first reported a position in RXO in Q4 2022 and held it in 1 quarter.
  • Aviva's RXO position peaked at $232K in Q4 2022.
  • 281 funds tracked by Wall St. Rank held RXO as of Q1 2023.

Based on Aviva's 13F filing for Q1 2023, filed 12 May 2023.